Coronavirus Dashboard - Jack Janasiewicz, CFA Garrett Melson, CFA - Natixis Investment Managers

Page created by Dwayne Franklin
 
CONTINUE READING
Coronavirus Dashboard - Jack Janasiewicz, CFA Garrett Melson, CFA - Natixis Investment Managers
Jack Janasiewicz, CFA®
Portfolio Strategist

Garrett Melson, CFA®
Associate Portfolio Strategist
                                          Coronavirus Dashboard
Portfolio Research and Consulting Group
Natixis Investment Managers                       FOR FINANCIAL PROFESSIONALS ONLY
Issue                           What We Are Watching                            Comments                                Risk
                                                         •      Fatality rate – will the virus   •   Confirmed cases likely underreported
                                                                prove to be more deadly than     •   Only most serious cases being              Second Wave:
            •    Data integrity – do we trust China’s           suspected?                           admitted and reported
                 numbers?                                •      New confirmed cases – how        •   Capacity constraints imply those with •    Quarantines lifted,
            •    Quality of reporting – is the data             contagious is the virus?             mild symptoms sent home                    factories
 Hubei           properly characterized?                 •      Consumer confidence/             •   Fatality rate artificially high given
            •    Access to care – does Hubei have               business sentiment – are                                                        restarting, public
                                                                                                     those with mild symptoms not
                 enough hospital space and staff to             individuals/business resuming                                                   transportation
                                                                                                     registered and sent home
                 effectively deal with outbreak?                normal behavior?                 •   Rate of contagion appears to be            filling
                                                         •      Are cases re-emerging –              declining – watching for second wave
                                                                second infection cycle?                                                     •   Increased public
                                                         •     New confirmed cases – is the                                                     contact leads to
                                                               virus spreading outside of                                                       reacceleration of
                                                                                                 •   Data outside of Hubei broadly reliable
China ex-   •    Data integrity – do we trust China’s          Hubei?                                                                           contagion in
                                                                                                 •   Failure to report is punishable
                 numbers?                                •     Consumer confidence/
 Hubei                                                                                           •   World Health Organization has              China
            •    Quality of reporting – is the data            business sentiment – are
                                                                                                     endorsed data
                 properly characterized?                       individuals/business resuming
                                                                                                 •   Rate of contagion rapidly declining    •   Signs virus may
                                                               normal behavior?
                                                         •     Recovery trends                                                                  be asymptomatic
                                                         •     New confirmed cases – is the
            •    Data integrity – quality of data much
                                                                                                                                            •   Possible longer
                                                               virus spreading outside of        •   Developed World – better equipped
                 stronger.                                     China?                                to deal with virus
                                                                                                                                                incubation period
 Rest of    •    Access to quality care – greater        •     Singapore – indicator of          •   Access to better care and more
                 number and higher quality of care             ability of developed                  providers
 World      •                                                                                                                               Belated overreaction
                 Hotspot flareups                              economies to respond              •   Emerging World – ill-equipped to
                                                         •     Will the US see an                    deal with outbreak, watching Africa        by markets.
                                                               outbreak?

            Source: Natixis PRCG.
                                                              FOR FINANCIAL PROFESSIONALS ONLY
Key Risk: Duration of outbreak
                       How long it takes to show virus is under control will determine economic impact.

                                                                                                                                                           Duration of
Duration of

                         Weeks                                                                                                 Months

                                                                                                                                                            outbreak
 outbreak

                         U Shaped                           W Shaped                          L Shaped                           Elevator
                         Recovery                           Recovery                          Recovery                            Shaft
                                                                                                                                 Recovery
              •   Short term pain for long term   •   Contagion spreads modestly   •   Contagion spreads overseas     •   Contagion spreads
                  gain                                overseas                         as second wave spreads             significantly overseas
              •   Draconian measures prove        •   Draconian measures prove         throughout China               •   Sudden stop of economic
                  successful in stemming              successful in initially      •   Harsher response from              activity triggered by
                  contagion                           stemming contagion but           Chinese authorities grinds         aggressive measures to limit
              •   Reported cases peak soon            second wave in China             domestic economy to halt           contagion
              •   PBoC policy stimulus puts           emerges as quarantines are   •   Foreign governments            •   Global monetary policy
                  floor under consumer and            lifted                           impose stricter controls on        ineffective in supporting risk
                  business confidence and         •   Global supply chains/risk        travel/imports/business with       appetite/consumer
                  supply chains come back             appetite/consumer and            China and impose own               confidence/business
                  online in a reasonable time         business sentiment dented        measures to limit spread of        sentiment and are unable to
                  period                          •   Global fiscal and monetary       virus within their borders         counter supply shock
              •   Buy the Dip mentality and           stimulus puts floor under    •   Global monetary policy helps   •   Nascent global economic
                  Fear Of Missing Out provide         consumer and business            support risk appetite/             recovery reverses and
                  the backdrop for a sharp            confidence and supply            consumer and business              recession fears re-emerge
                  recovery in risk assets             chains come back online          sentiment to offset demand
                                                      after a limited delay            shock but unable to counter
                                                                                       supply shock
                                                                                   •   Tourism/commodities suffer

          Source: Natixis PRCG.
                                                               FOR FINANCIAL PROFESSIONALS ONLY
Daily Change in Confirmed Cases                                                                          Daily Change in Confirmed Cases: Hubei
                           2,000                                                                                                        16,000
                                                                                      China ex-Hubei
                           1,800                                                                                                        14,000                         Spike from CT scan
                                                                                      Rest of World                                                                     confirmed cases
                           1,600
                                                                                                                                        12,000
                           1,400
# of Persons

                                                                                                                 # of Persons
                           1,200                                                                                                        10,000
                           1,000                                                                                                         8,000
                            800                                                                                                          6,000
                            600
                                                                                                                                         4,000
                            400
                            200                                                                                                          2,000
                              0                                                                                                                0
                                   1/22 1/25 1/28 1/31 2/3       2/6    2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1                                      1/22 1/25 1/28 1/31 2/3    2/6    2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1

                                                          Confirmed Cases                                                                                                 Fatality Rate
                           100,000                                                                                                      6.0%
                                                                                                                                                                                       Total
                                                                                                                                                                                       China ex-Hubei
                                                                                                                                        5.0%
# of Persons (log scale)

                            10,000                                                                                                                                                     Hubei

                                                                                                                 % of Confirmed Cases
                                                                                                                                        4.0%
                             1,000
                                                                                                                                        3.0%
                              100
                                                                                            China ex-Hubei                              2.0%
                                                                                            Hubei
                                  10
                                                                                            Rest of World                               1.0%

                                   1                                                                                                    0.0%
                                       1/22 1/25 1/28 1/31 2/3    2/6    2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1                                 1/22 1/25 1/28 1/31 2/3       2/6    2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1

Source: Natixis PRCG, John Hopkins University. Data as of 3/2/20. Note: Confirmed cases in Hubei province include CT clinically
confirmed cases between 2/12/20 and 2/18/20 (spike in daily change reflects prior CT confirmed cases).
                                                               FOR FINANCIAL PROFESSIONALS ONLY
Confirmed Cases: Hot Spots                                                              Daily Change in Confirmed Cases: Hot Spots
               5,000                                                                                              900
                               Japan                                                                                              Japan
               4,500                                                                                              800
                               South Korea                                                                                        South Korea
               4,000                                                                                              700
                               Iran                                                                                               Iran
               3,500
                               Italy                                                                              600
# of Persons

                                                                                                   # of Persons
               3,000                                                                                                              Italy
                               Singapore                                                                          500
               2,500                                                                                                              Singapore
                                                                                                                  400
               2,000
                                                                                                                  300
               1,500
               1,000                                                                                              200
                500                                                                                               100
                  0                                                                                                0
                       1/22 1/25 1/28 1/31 2/3    2/6   2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1                           1/22 1/25 1/28 1/31     2/3   2/6   2/9    2/12 2/15 2/18 2/21 2/24 2/27   3/1

                                        Confirmed Cases: By Region                                                              Daily Change in Confirmed Cases: By Region
               6,000                                                                                              900
                               North America                Latin America                                                      North America                      Latin America
                                                                                                                  800
               5,000                                                                                                           Europe                             Asia ex-China
                               Europe                       Asia ex-China                                         700
                                                                                                                               Australia/New Zealand              Middle East/Africa
               4,000                                                                                              600
# of Persons

                                                                                                   # of Persons
                               Australia/New Zealand        Middle East/Africa                                    500
               3,000
                                                                                                                  400
               2,000                                                                                              300
                                                                                                                  200
               1,000
                                                                                                                  100
                  0                                                                                                0
                       1/22 1/25 1/28 1/31 2/3    2/6   2/9 2/12 2/15 2/18 2/21 2/24 2/27 3/1                           1/22 1/25 1/28 1/31     2/3   2/6   2/9    2/12 2/15 2/18 2/21 2/24 2/27   3/1

Source: Natixis PRCG, John Hopkins University. Data as of 3/2/20.

                                                                                 FOR FINANCIAL PROFESSIONALS ONLY
China As a Roadmap?
                                                                      Daily Change in Confirmed Cases
                                                                                    (1/20/20 - 3/2/20)
                   4,000                                                                                                                                      4,000

                   3,500                                                                                                                                      3,500
                                    China (Advanced 1M)     Rest of World
                   3,000                                                                                                                                      3,000

                   2,500                                                                                                                                      2,500
    # of Persons

                                                                                                                                                                      # of Persons
                   2,000                                                                                                                                      2,000

                   1,500                                                                                                                                      1,500

                   1,000                                                                                                                                      1,000

                    500                                                                                                                                       500

                      0                                                                                                                                       0
                           1/20   1/24   1/28   2/1   2/5   2/9    2/13     2/17   2/21   2/25   2/29    3/4   3/8   3/12   3/16   3/20   3/24   3/28   4/1

Source: Natixis PRCG, John Hopkins University. Data as of 3/2/20.

                                                                            FOR FINANCIAL PROFESSIONALS ONLY
Mainland China Case and Mortality Rate by Age Group
                                                           As of February 11, 2020
                                                       Confirmed Cases                                  Deaths
Age Group               Confirmed Cases (#)                                        Deaths (#)                           Case Fatality Rate
                                                      (% of Total Cases)                          (% of Total Deaths)
0-9                                416                       0.9%                       0                0.0%                 0.0%
10–19                              549                       1.2%                       1                0.1%                 0.2%
20–29                             3,619                      8.1%                       7                0.7%                 0.2%
30–39                             7,600                     17.0%                       18               1.8%                 0.2%
40–49                             8,571                     19.2%                       38               3.7%                 0.4%
50–59                            10,008                     22.4%                      130               12.7%                1.3%
60–69                             8,583                     19.2%                      309               30.2%                3.6%
70–79                             3,918                      8.8%                      312               30.5%                8.0%
≥80                               1,408                      3.2%                      208               20.3%                14.8%
Total                            44,672                    100.0%                     1,023             100.0%                2.3%

Source: Natixis PRCG, Chinese Center for Disease Control and Prevention.

                                                               FOR FINANCIAL PROFESSIONALS ONLY
Chinese Economic Supportive Measures
•   Government measures announced thus far appear to be targeted towards easing employment pressures and assisting companies with short term
    funding concerns.

•   PBoC plans to lower the targeted RRR for qualified institutions.

•   In an attempt to help SMEs, the PBoC raised the refinancing quota by CNY500bln for industries related to farming, livestock, travel, and transportation.

•   Shanghai announced that it will provide subsidies for cinemas and movie distribution companies.

•   Shandong allocated CNY12.7bln to aid transportation projects, targeting roads and railways.

•   NDRC reiterated that the 2020 economic and social targets could still be achieved and that the central government will continue to roll out fiscal support.

•   PBoC mentioned that they plan to accelerate the implementation of CNY300bln in refinancing loans, adjust the targeted RRR cuts for specific financing, and
    support manufacturing, exports and supply chains through 3 policy banks.

•   MoF stated that central and regional governments will start a CNY100bln COVID-19 prevention fund.

•   Anhui province rolled out 17 measures to support agriculture companies, including work resumption acceleration and credit support.

•   Henan province rolled out 18 measures to support the real estate industry, including temporary credit expansion and a delayed or cut in fee collection.

•   State Taxation Administration announced that it would temporarily waive the social security collection for companies based on regional financing conditions.
    Specifically, SMEs and big companies would be waived by no more than 5 and 3 months respectively.

•   Hebei province announced a CNY50bln fund to support work resumption, COVID 19 prevention and infrastructure spending.

•   PBoC cut the LPR rate by 10bps to 4.05% for 1year loans and 5bps to 4.75% for 5 year loans.

•   ICBC raised the credit loan limit to CNY100mln and lending discounts to epidemic prevention SMEs and Hubei SMEs.

    Source: Natixis PRCG. SOE are State Owned Enterprises. SMEs are Small and Medium Enterprises. RRR is the required reserve ratio for banks.

                                                                                       FOR FINANCIAL PROFESSIONALS ONLY
Other Economic Supportive Measures

•   Hong Kong
         • Government announced fiscal stimulus measures totaling $15.4B including $1,284 cash payments to all 10,000 adult permanent residents and a salary tax cut for 2 million
            workers

•   Singapore
         • Government announced 2020 budget with widest deficit since 1997 as the government pledged $570M to counter the virus outbreak and an additional $4B to support
            businesses and consumers and delay the increase of a goods and services tax

•   South Korea
         • Bank of Korea left policy rate unchanged but announced an increase in the cap for cheap loans available to companies affected by the virus outbreak and left door open to
            future rate cuts
         • Finance Minister announced government would spend $13.2B in support to businesses and individuals with plans to approve an additional $5B in aid

•   G7
            •   Released joint communique following teleconference between G7 finance ministers and central bank governors affirming the group’s commitment to use all appropriate
                policy tools to achieve strong, sustainable growth and safeguard against downside risks though no specific measures were announced

•   EU
            •   European Union expected to grant waivers under EU fiscal flexibility clauses rules to allow increased spending by countries impacted by the virus
            •   Rumors of possible joint fiscal response among member finance ministers

•   Italy
            •   Italy announced $4B stimulus package to help cope with the outbreak including tax and mortgage payment delays as well as broader yet-to-be unveiled measures

•   Germany
        • German Finance Minister Olaf Scholz considering a temporary suspension of constitutional debt limits though measure is likely to be contentious in Parliament

•   Australia
         • Reserve Bank of Australia announced 25 basis point cut citing virus outbreak as having significant effect on Australian economy, particularly within education and travel

•   United States
         • Fed announced emergency intra-meeting rate cut of 50 basis points after unanimous vote recognizing the evolving risks the epidemic posts to economic activity

    Source: Natixis PRCG.

                                                                         FOR FINANCIAL PROFESSIONALS ONLY
Disclosure
This presentation is provided for informational purposes only and should not be construed as investment advice. References to specific securities or industries
should not be considered a recommendation. Any opinions or forecasts contained herein reflect the subjective judgments and assumptions of the authors only and
do not necessarily reflect the views of Natixis Investment Managers, or any of its affiliates. There can be no assurance that developments will transpire as
forecasted and actual results will be different. Data and analysis does not represent the actual or expected future performance of any investment product. We
believe the information, including that obtained from outside sources, to be correct, but we cannot guarantee its accuracy. The information is subject to change at
any time without notice.

This presentation contains “forward-looking statements" concerning activities, events or developments that the Portfolio Research and Consulting Group (PRCG)
expects or believes may occur in the future. These statements reflect assumptions and analyses made by PRCG analysts based on their experience and
perception of historical trends, current conditions, expected future developments, and other factors they believe are relevant. Because these forward-looking
statements may be subject to risks and uncertainties beyond PRCG’s control, they are not guarantees of any future performance. Actual results or developments
may differ materially, and readers are cautioned not to place undue reliance on the forward-looking statements.

Index information is used to illustrate general asset class exposure, and not intended to represent performance of any investment product or strategy.

This document may contain references to third party copyrights, indexes, and trademarks, each of which is the property of its respective owner. Such owner is not
affiliated with Natixis Investment Managers or any of its related or affiliated companies (collectively “Natixis”) and does not sponsor, endorse or participate in the
provision of any Natixis services, funds or other financial products.

Index information contained herein is derived from third parties and is provided on an “as is” basis. The user of this information assumes the entire risk of use of
this information. Each of the third party entities involved in compiling, computing or creating index information disclaims all warranties (including, without limitation,
any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to such
information.

CFA® and Chartered Financial Analyst® are registered trademarks owned by the CFA Institute.

Natixis Distribution, L.P. is a limited purpose broker-dealer and the distributor of various registered investment companies for which advisory services are provided
by affiliates of Natixis Investment Managers.                                                                                                      Adtrax: 1438702.65.8
                                                                                                                                                Expiration Date: 12/31/2020
Natixis Distribution, L.P. is located at 888 Boylston St., Boston, MA 02199.

                                                               FOR FINANCIAL PROFESSIONALS ONLY
Additional Notes
This material has been provided for information purposes only to investment service providers or other Professional Clients or Qualified Investors and, when required by local regulation, only at their written request. This material must not be used with Retail Investors. In the E.U. (outside of
the UK and France): Provided by Natixis Investment Managers S.A. or one of its branch offices listed below. Natixis Investment Managers S.A. is a Luxembourg management company that is authorized by the Commission de Surveillance du Secteur Financier and is incorporated under
Luxembourg laws and registered under n. B 115843. Registered office of Natixis Investment Managers S.A.: 2, rue Jean Monnet, L-2180 Luxembourg, Grand Duchy of Luxembourg. Italy: Natixis Investment Managers S.A., Succursale Italiana (Bank of Italy Register of Italian Asset
Management Companies no 23458.3). Registered office: Via San Clemente 1, 20122 Milan, Italy. Germany: Natixis Investment Managers S.A., Zweigniederlassung Deutschland (Registration number: HRB 88541). Registered office: Im Trutz Frankfurt 55, Westend Carrée, 7. Floor, Frankfurt
am Main 60322, Germany. Netherlands: Natixis Investment Managers, Nederlands (Registration number 50774670). Registered office: Stadsplateau 7, 3521AZ Utrecht, the Netherlands. Sweden: Natixis Investment Managers, Nordics Filial (Registration number 516405-9601 - Swedish
Companies Registration Office). Registered office: Kungsgatan 48 5tr, Stockholm 111 35, Sweden. Spain: Natixis Investment Managers, Sucursal en España. Registered office: Serrano n°90, 6th Floor, 28006 Madrid, Spain. Belgium: Natixis Investment Managers S.A., Belgian Branch,
Louizalaan 120 Avenue Louise, 1000 Brussel/Bruxelles, Belgium. ● In France: Provided by Natixis Investment Managers International – a portfolio management company authorized by the Autorité des Marchés Financiers (French Financial Markets Authority - AMF) under no. GP 90-009,
and a public limited company registered in the Paris Trade and Companies Register under no. 329 450 738. Registered office: 43 avenue Pierre Mendès France, 75013 Paris. ● In Switzerland: Provided by Natixis Investment Managers, Switzerland Sàrl, Rue du Vieux Collège 10, 1204
Geneva, Switzerland or its representative office in Zurich, Schweizergasse 6, 8001 Zürich. ● In the British Isles: Provided by Natixis Investment Managers UK Limited which is authorised and regulated by the UK Financial Conduct Authority (register no. 190258) - registered office: Natixis
Investment Managers UK Limited, One Carter Lane, London, EC4V 5ER. When permitted, the distribution of this material is intended to be made to persons as described as follows: in the United Kingdom: this material is intended to be communicated to and/or directed at investment
professionals and professional investors only; in Ireland: this material is intended to be communicated to and/or directed at professional investors only; in Guernsey: this material is intended to be communicated to and/or directed at only financial services providers which hold a license from
the Guernsey Financial Services Commission; in Jersey: this material is intended to be communicated to and/or directed at professional investors only; in the Isle of Man: this material is intended to be communicated to and/or directed at only financial services providers which hold a
license from the Isle of Man Financial Services Authority or insurers authorised under section 8 of the Insurance Act 2008.
 ● In the DIFC: Provided in and from the DIFC financial district by Natixis Investment Managers Middle East (DIFC Branch) which is regulated by the DFSA. Related financial products or services are only available to persons who have sufficient financial experience and understanding to
participate in financial markets within the DIFC, and qualify as Professional Clients or Market Counterparties as defined by the DFSA. No other Person should act upon this material. Registered office: Office 23, Level 15, The Gate Building, East Wing, DIFC, PO Box 506752, Dubai, United
Arab Emirates. ● In Taiwan: Provided by Natixis Investment Managers Securities Investment Consulting (Taipei) Co., Ltd., a Securities Investment Consulting Enterprise regulated by the Financial Supervisory Commission of the R.O.C. Registered address: 34F., No. 68, Sec. 5, Zhongxiao
East Road, Xinyi Dist., Taipei City 11065, Taiwan (R.O.C.), license number 2018 FSC SICE No. 024, Tel. +886 2 8789 2788. ● In Singapore: Provided by Natixis Investment Managers Singapore (name registration no. 53102724D) to distributors and institutional investors only. Natixis
Investment Managers Singapore is a division of Ostrum Asset Management Asia Limited (company registration no. 199801044D). • In Hong Kong: Provided by Natixis Investment Managers Hong Kong Limited to institutional/ corporate professional investors only. ● In Australia: Provided
by Natixis Investment Managers Australia Pty Limited (ABN 60 088 786 289) (AFSL No. 246830) and is intended for the general information of financial advisers and wholesale clients only. ● In New Zealand: This document is intended for the general information of New Zealand wholesale
investors only. This is not a regulated offer for the purposes of the Financial Markets Conduct Act 2013 (FMCA) and is only available to New Zealand investors who have certified that they meet the requirements in the FMCA for wholesale investors. Natixis Investment Managers Australia Pty
Limited is not a registered financial service provider in New Zealand. ● In Latin America: Provided by Natixis Investment Managers S.A. ● In Chile: Esta oferta privada se inicia el día de la fecha de la presente comunicación. La presente oferta se acoge a la Norma de Carácter General
N° 336 de la Superintendencia de Valores y Seguros de Chile. La presente oferta versa sobre valores no inscritos en el Registro de Valores o en el Registro de Valores Extranjeros que lleva la Superintendencia de Valores y Seguros, por lo que los valores sobre los cuales ésta versa, no
están sujetos a su fiscalización. Que por tratarse de valores no inscritos, no existe la obligación por parte del emisor de entregar en Chile información pública respecto de estos valores. Estos valores no podrán ser objeto de oferta pública mientras no sean inscritos en el Registro de Valores
correspondiente. ● In Colombia: Provided by Natixis Investment Managers S.A. Oficina de Representación (Colombia) to professional clients for informational purposes only as permitted under Decree 2555 of 2010. Any products, services or investments referred to herein are rendered
exclusively outside of Colombia. This material does not constitute a public offering in Colombia and is addressed to less than 100 specifically identified investors. ● In Mexico: Provided by Natixis IM Mexico, S. de R.L. de C.V., which is not a regulated financial entity, securities intermediary,
or an investment manager in terms of the Mexican Securities Market Law (Ley del Mercado de Valores) and is not registered with the Comisión Nacional Bancaria y de Valores (CNBV) or any other Mexican authority. Any products, services or investments referred to herein that require
authorization or license are rendered exclusively outside of Mexico. While shares of certain ETFs may be listed in the Sistema Internacional de Cotizaciones (SIC), such listing does not represent a public offering of securities in Mexico, and therefore the accuracy of this information has not
been confirmed by the CNBV. Natixis Investment Managers is an entity organized under the laws of France and is not authorized by or registered with the CNBV or any other Mexican authority. Any reference contained herein to “Investment Managers” is made to Natixis Investment
Managers and/or any of its investment management subsidiaries, which are also not authorized by or registered with the CNBV or any other Mexican authority. ● In Uruguay: Provided by Natixis Investment Managers Uruguay S.A., a duly registered investment advisor, authorised and
supervised by the Central Bank of Uruguay. Office: San Lucar 1491, Montevideo, Uruguay, CP 11500. The sale or offer of any units of a fund qualifies as a private placement pursuant to section 2 of Uruguayan law 18,627. ● The above referenced entities are business development units of
Natixis Investment Managers, the holding company of a diverse line-up of specialised investment management and distribution entities worldwide. The investment management subsidiaries of Natixis Investment Managers conduct any regulated activities only in and from the jurisdictions in
which they are licensed or authorised. Their services and the products they manage are not available to all investors in all jurisdictions. It is the responsibility of each investment service provider to ensure that the offering or sale of fund shares or third party investment services to its clients
complies with the relevant national law.
In the United States: Provided by Natixis Distribution, L.P., 888 Boylston St., Boston, MA 02199 for U.S. financial advisors who do business with investors who are not U.S. Persons (as that term is used in Regulation S under the Securities Act of 1933) or persons otherwise
present in the U.S. It may not be redistributed to U.S. Persons or persons present in the U.S. Natixis Investment Managers includes all of the investment management and distribution entities affiliated with Natixis Distribution, L.P. and Natixis Investment Managers S.A.
This document may contain references to copyrights, indexes and trademarks that may not be registered in all jurisdictions. Third party registrations are the property of their respective owners and are not affiliated with Natixis Investment Managers or any of its related or affiliated companies
(collectively “Natixis”). Such third party owners do not sponsor, endorse or participate in the provision of any Natixis services, funds or other financial products.
The index information contained herein is derived from third parties and is provided on an “as is” basis. The user of this information assumes the entire risk of use of this information. Each of the third party entities involved in compiling, computing or creating index information, disclaims all
warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to such information.
The provision of this material and/or reference to specific securities, sectors, or markets within this material does not constitute investment advice, or a recommendation or an offer to buy or to sell any security, or an offer of any regulated financial activity. Investors should consider the
investment objectives, risks and expenses of any investment carefully before investing. The analyses, opinions, and certain of the investment themes and processes referenced herein represent the views of the portfolio manager(s) as of the date indicated. These, as well as the
portfolio holdings and characteristics shown, are subject to change. There can be no assurance that developments will transpire as may be forecasted in this material. Although Natixis Investment Managers believes the information provided in this material to be reliable, including that from
third party sources, it does not guarantee the accuracy, adequacy, or completeness of such information. May not be redistributed, published, or reproduced, in whole or in part. Amounts shown are expressed in USD unless otherwise indicated.
You can also read